Sanofi to produce 100 million Pfizer/BioNTech vaccine doses, CEO says
Reuters | Paris | Updated: 26-01-2021 23:03 IST | Created: 26-01-2021 22:54 IST
French pharma giant Sanofi will produce more than 100 million doses of the COVID-19 vaccine developed by its competitors Pfizer and BioNTech by the end of the year, CEO Paul Hudson told Le Figaro newspaper in an interview published on Tuesday.
As Sanofi and its British partner GlaxoSmithKline have delayed the launch of their shot to late 2021, the French company decided to approach Pfizer "in order to be helpful as of now", Hudson said, adding that an agreement with the U.S. company had been reached.
(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)
ALSO READ
New hate symbols on U.S. warships including noose spark Navy condemnation
U.S. Senate panel sets Feb. 22-23 hearing for attorney general nominee Garland
U.S. users most popular targets for email attackers: Google study
Lyon extends streak with 5-1 win over Ajaccio in French Cup
Sports News Roundup: U.S. safety board cites poor pilot decisions as likely cause of Kobe Bryant fatal crash; Sunday's Super Bowl TV audience lowest in 15 years and more